Sort
261,768 grants matching “gene therapy”
Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease
$1,499,930Victor John Thannickal · Tulane University Of Louisiana · P01 · FY2021 · HL
Manufacture of an intracerebroventricular Enzyme Replacement Therapy for CLN1 Batten Disease
$1,499,923Sean Ekins · Collaborations Pharmaceuticals, Inc. · R44 · FY2022 · NS
Manufacture of an intracerebroventricular Enzyme Replacement Therapy for CLN1 Batten Disease
$1,499,923Sean Ekins · Collaborations Pharmaceuticals, Inc. · R44 · FY2023 · NS
OTHER FUNCTIONS PHASE 0 CARBOPLATIN MICRODOSING DIAGNOSTIC TRIAL.
$1,499,894Paul Henderson · Accelerated Medical Diagnostics, Llc · N44 · FY2012 · CA
Study of hereditary prostate cancer and human artificial chromosomes
$1,499,749Vladimir Larionov · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Development of modified human thioredoxin as an inhaled biologic therapeutic for cystic fibrosis
$1,499,635Peter B Heifetz · Orpro Therapeutics, Inc. · R44 · FY2018 · HL
Clinical evaluation of mTORC1 inhibition for geroprotection.
$1,499,625Adam R Konopka · University Of Wisconsin-Madison · U01 · FY2022 · AG
Comprehensive Sickle Cell Center
$1,499,547Clinton H. Joiner · Cincinnati Childrens Hosp Med Ctr · U54 · FY2009 · HL
Trans-BBB AAV9 gene therapy targeting CNS neuropathy of MPS I
$1,499,504Douglas M McCarty · Neurogt, Inc. · R44 · FY2025 · NS
Improved Diagnosis and Treatment of Cushing's Disease
$1,499,462Prashant Chittiboina · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
$1,499,440Matthew Wayne Johnson · Johns Hopkins University · U01 · FY2021 · DA
OTHER FUNCTIONS - R&D BIOMEDICAL (BASIC RESEARCH)
$1,499,412Dr. David Hout · Insight Genetics, Inc. · N01 · FY2013 · CA
Clinical and Mechanistic Investigations of Salivary Gland Dysfunction
$1,499,358Blake Warner · National Institute Of Dental & Craniofacial Research · ZIA · FY2021 · DE
EDGE: Establishing functional genomics in Hydra to study stem cells and regeneration
$1,499,305Celina Juliano · University Of California-Davis · · FY2018 · BIO
Isolation, characterization, and transplantation of candidate stem cells
$1,499,275John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Preclinical and Clinical Studies in Gene Therapy for Sickle Cell Disease
$1,499,275John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
ETIB Clinical Research Core
$1,498,841Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2021 · CA
IGF::OT::IGF BLOOD TEST TO PREDICT RADIATION TOXICITY IN PATIENTS TREATED WITH RADIATION THERAPY
$1,498,643Ph.d., Robert Terbrueggen · Dxterity Diagnostics, Inc. · N44 · FY2016 · CA
A Functional Companion Diagnostic Test to Predict Optimal Therapy for Melanoma
$1,498,569Greg Bertenshaw · Biomarker Strategies, Llc · N44 · FY2013 · CA
Molecular Therapeutics for Epithelial Disorders
$1,498,566Paul A Khavari · Stanford University · P01 · FY2006 · AR
Mechanisms of Sensory Hair Cell Survival and Death
$1,498,512Lisa L Cunningham · National Institute On Deafness And Other Communication Disorders · ZIA · FY2014 · DC
Structure-Guided Design of Broadly Neutralizing Lassa Virus BiSpecific Antibodies
$1,498,398Luis Manuel Branco · Zalgen Labs, Llc · R01 · FY2019 · AI
Final clinical studies for submission of a pre-market approval application to the FDA for a Bionic Pancreas that automates type 1 diabetes management
$1,498,323Edward Damiano · Boston University (Charles River Campus) · UC4 · FY2015 · DK
Emory Specialized Center of Research Excellence (SCORE) on Sex Differences
$1,498,219Ighovwerha Ofotokun · Emory University · U54 · FY2019 · AG
Development of a TRAIL-based therapy for alcohol related chronic pancreatitis
$1,498,190Victor V Roschke · Theraly Fibrosis, Inc. · U44 · FY2020 · AA